Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acyclovir sodium is the sodium salt form of acyclovir, a synthetic purine nucleoside analogue with potent antiviral activity against herpes simplex viruses (HSV-1 and HSV-2) and varicella-zoster virus (VZV). It acts as a prodrug that requires phosphorylation by viral thymidine kinase to its active form, acyclovir triphosphate. This active metabolite competitively inhibits viral DNA polymerase and incorporates into the growing viral DNA chain, leading to premature chain termination and inhibition of viral replication. The sodium salt formulation is primarily used for intravenous administration in severe or systemic infections, such as herpes simplex encephalitis, neonatal herpes, and infections in immunocompromised patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acyclovir sodium.